Clinical Trial Update: Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG) [Phase 3]

View source ↗

Summary

Phase 3 multicenter randomized trial by AMLCG on biology and treatment strategies for acute myeloid leukemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital Muenster | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED